The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42
Open accessAbstract
A key event in Alzheimer's disease (AD) pathogenesis is the conversion of the peptide beta-amyloid (Abeta) from its soluble monomeric form into various aggregated morphologies in the brain. Preventing aggregation of Abeta is being actively pursued as a primary therapeutic strategy for treating AD. Trehalose, a simple disaccharide, has been shown to be effective in preventing the deactivation of numerous proteins and in protecting cells against stress. Here, we show that trehalose is also effective in inhibiting aggregation of Abeta and reducing its cytotoxicity, although it shows differential effects toward Abeta40 and Abeta42. When co-incubated with Abeta40, trehalose inhibits formation of both fibrillar and oligomeric morphologies as determined by fluorescence staining and atomic force microscopy (AFM). However, when co-incubated with Abeta42, trehalose inhibits formation only of the fibrillar morphology, with significant oligomeric formation still present. When aggregated mixtures were incubated with SH-SY5Y cells, trehalose was shown to reduce the toxicity of Abeta40 mixtures, but not Abeta42. These results provide additional evidence that aggregation of Abeta into soluble oligomeric forms is a pathological step in AD and that Abeta42 in particular is more susceptible to forming these toxic oligomers than Abeta40. These results also suggest that the use of trehalose, a highly soluble, low-priced sugar, as part of a potential therapeutic cocktail to control Abeta peptide aggregation and toxicity warrants further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
THE ROLE OF VITRIFICATION IN ANHYDROBIOSIS
Crowe, J. H., Carpenter, J. F., & Crowe, L. M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.73 · Cited by 1,357
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 875
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 723 · cited 4×
“, 1999); (3) proteins, such as chaperones and proteasomal proteins (Petrucelli et al., 2004; Xie and Guo, 2004); (4) enzymes, such as angiotensinconverting enzyme (ACE) (Hu et al.”
BackgroundInfluentialMultiple Effects of Trehalose on Protein Folding In Vitro and In Vivo
Singer, M. A., & Lindquist, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80064-7 · Cited by 698
Benaroudj, N., Lee, D. H., & Goldberg, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101487200 · Cited by 668
Why Is Trehalose an Exceptional Protein Stabilizer?
Kaushik, J. K., & Bhat, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300815200 · Cited by 625
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 585
Allison, S. D., Chang, B., Randolph, T. W., & Carpenter, J. F. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1175 · Cited by 546
Thermotolerance in Saccharomyces cerevisiae: the Yin and Yang of trehalose
Singer, M. A., & Lindquist, S. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01251-7 · Cited by 482
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454
Physiological roles of trehalose in bacteria and yeasts: a comparative analysis
Argüelles, J. C. (2000) · Archives of Microbiology · doi:10.1007/s002030000192 · Cited by 426
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 398
Hu, J., Igarashi, A., Kamata, M., & Nakagawa, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104068200 · Cited by 360
Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., & Fink, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0770fje · Cited by 258
IR and Raman spectroscopic studies of the interaction of trehalose with hen egg white lysozyme
Belton, P. S., & Gil, A. M. (1994) · Biopolymers · doi:10.1002/bip.360340713 · Cited by 246
Trehalose–protein interaction in aqueous solution
Lins, R. D., Pereira, C. S., & Hünenberger, P. H. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10632 · Cited by 242
Carninci, P., Nishiyama, Y., Westover, A., Itoh, M., Nagaoka, S., Sasaki, N., Okazaki, Y., Muramatsu, M., & Hayashizaki, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.520 · Cited by 239
Inhibition of insulin amyloid formation by small stress molecules
Arora, A., Ha, C., & Park, C. B. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00326-6 · Cited by 228
Self-citationModified-Peptide Inhibitors of Amyloid β-Peptide Polymerization
Findeis, M. A., Musso, G. M., Arico-Muendel, C. C., Benjamin, H. W., Hundal, A. M., Lee, J.-J., Chin, J., Kelley, M., Wakefield, J., Hayward, N. J., et al. (1999) · Biochemistry · doi:10.1021/bi982824n · Cited by 222
Nordberg, A., Hellström‐Lindahl, E., Lee, M., Johnson, M., Mousavi, M., Hall, R., Perry, E., Bednar, I., & Court, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 209
Protein Reaction Kinetics in a Room-Temperature Glass
Hagen, S. J., Hofrichter, J., & Eaton, W. A. (1995) · Science · doi:10.1126/science.7638618 · Cited by 208
Shearman, M. S., Hawtin, S. R., & Tailor, V. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010218.x · Cited by 203
Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., & Selkoe, D. J. (1998) · Biochemistry · doi:10.1021/bi972029u · Cited by 186
Nichols, M. R., Moss, M. A., Reed, D. K., Lin, W.-L., Mukhopadhyay, R., Hoh, J. H., & Rosenberry, T. L. (2002) · Biochemistry · doi:10.1021/bi015985r · Cited by 179
Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization
Findeis, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00034-x · Cited by 174
Bergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., Perego, C., De Luigi, A., Vergani, C., & Grazia De Simoni, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0550-04.2004 · Cited by 146
Shimizu, T., Fukuda, H., Murayama, S., Izumiyama, N., & Shirasawa, T. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10350 · Cited by 130
Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity
Bang, O. Y., Hong, H., Kim, D. H., Kim, H., Boo, J. H., Huh, K., & Mook‐Jung, I. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.017 · Cited by 125
Liu, R., Yuan, B., Emadi, S., Zameer, A., Schulz, P., McAllister, C., Lyubchenko, Y. L., Goud, G. N., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi049933o · Cited by 113
Self-citationBiotechnological Applications of the Disaccharide Trehalose
Paiva, C. L. A., & Panek, A. D. (1996) · Biotechnology annual review · doi:10.1016/s1387-2656(08)70015-2 · Cited by 95
Structure and dynamics of three-way DNA junctions: atomic force microscopy studies
Shlyakhtenko, L. S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3472 · Cited by 89
The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide
Ashur‐Fabian, O., Segal-Ruder, Y., Skutelsky, E., Brenneman, D. E., Steingart, R. A., Giladi, E., & Gozes, I. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.005 · Cited by 84
Simola, M., Hänninen, A., Stranius, S., & Makarow, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01970.x · Cited by 76
Sola‐Penna, M., Ferreira‐Pereira, A., Lemos, A. D. P., & Meyer‐Fernandes, J. R. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00024.x · Cited by 73
Degradation of β-Amyloid by Proteolytic Antibody Light Chains
Rangan, S. K., Liu, R., Brune, D. C., Planque, S. A., Paul, S., & Sierks, M. R. (2003) · Biochemistry · doi:10.1021/bi035038d · Cited by 61
Self-citationФеофилова, Е. П. (2003) · Applied Biochemistry and Microbiology · doi:10.1023/a:1021774523465 · Cited by 53
Intersegmental interactions in supercoiled DNA: atomic force microscope study
Shlyakhtenko, L. S., Miloseska, L., Potaman, V. N., Sinden, R. R., & Lyubchenko, Y. L. (2003) · Ultramicroscopy · doi:10.1016/s0304-3991(03)00051-2 · Cited by 51
The Challenge of Inhibiting Aβ Polymerization
LeVine, H. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370167 · Cited by 41
Proteolytic Antibody Light Chains Alter β-Amyloid Aggregation and Prevent Cytotoxicity
Liu, R., McAllister, C., Lyubchenko, Y. L., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi0492354 · Cited by 35
Self-citationManoutcharian, K., Acero, G., Munguía, M. E., Becerril, B., Massieu, L., Govezensky, T., Ortíz, E., Marks, J. D., Cao, C., Ugen, K. E., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.005 · Cited by 34
AATF protects neural cells against oxidative damage induced by amyloid β-peptide
Xie, J., & Guo, Q. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.02.003 · Cited by 29
Cited by
Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142
Effect of trehalose on protein structure
Jain, N. K., & Roy, I. (2009) · Protein Science · doi:10.1002/pro.3 · Cited by 883
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Trehalose: Current Use and Future Applications
Ohtake, S., & Wang, Y. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22458 · Cited by 487
Natural products as a source of Alzheimer's drug leads
Williams, P., Sorribas, A., & Howes, M.-J. R. (2011) · Nat. Prod. Rep. · doi:10.1039/c0np00027b · Cited by 404
Metadata
- Authors
- LIU, R., BARKHORDARIAN, H., EMADI, S., PARK, C., & SIERKS, M.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 20
- Issue
- 1
- Pages
- 74-81
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2048061357
- Cited by
- 339
- References
- 52
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.